Increased miR-146a in Blood Cells of Rheumatoid Arthritis Patients
Author Information
Author(s): Pauley Kaleb M, Satoh Minoru, Chan Annie L, Bubb Michael R, Reeves Westley H, Chan Edward KL
Primary Institution: University of Florida
Hypothesis
The study investigates the expression of specific microRNAs in peripheral blood mononuclear cells from rheumatoid arthritis patients compared to healthy controls.
Conclusion
Rheumatoid arthritis patients show significantly higher levels of certain microRNAs, which may serve as markers for disease activity.
Supporting Evidence
- RA patients exhibited 2.6-fold higher miR-146a expression compared to healthy controls.
- High levels of miR-146a and miR-16 correlated with active disease.
- The expression of miRNA let-7a was not significantly different between RA patients and healthy controls.
Takeaway
This study found that people with rheumatoid arthritis have more of a tiny molecule called miR-146a in their blood, which might help doctors understand how bad their disease is.
Methodology
The study analyzed microRNA expression in peripheral blood mononuclear cells using quantitative real-time PCR.
Limitations
The study's findings need confirmation in a larger and well-defined cohort.
Participant Demographics
The study included 16 rheumatoid arthritis patients and 13 control individuals (4 disease controls and 9 healthy donors).
Statistical Information
P-Value
p<0.01 for miR-146a and p<0.05 for miR-155, miR-132, and miR-16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website